Suppr超能文献

细胞因子:在动脉粥样硬化疾病进展中的作用及潜在治疗靶点

Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets.

作者信息

Moss Joe We, Ramji Dipak P

机构信息

Cardiff School of Biosciences, Cardiff University, Sir Martin Evans Building, Museum Avenue, Cardiff, CF10 3AX, UK.

出版信息

Future Med Chem. 2016 Jul;8(11):1317-30. doi: 10.4155/fmc-2016-0072. Epub 2016 Jun 30.

Abstract

Atherosclerosis, the primary cause of cardiovascular disease (CVD), is a chronic inflammatory disorder in the walls of medium and large arteries. CVD is currently responsible for about one in three global deaths and this is expected to rise in the future due to an increase in the prevalence of obesity and diabetes. Current therapies for atherosclerosis mainly modulate lipid homeostasis and while successful at reducing the risk of a CVD-related death, they are associated with considerable residual risk and various side effects. There is, therefore, a need for alternative therapies aimed at regulating inflammation in order to reduce atherogenesis. This review will highlight the key role cytokines play during disease progression as well as potential therapeutic strategies to target them.

摘要

动脉粥样硬化是心血管疾病(CVD)的主要病因,是中大型动脉血管壁的一种慢性炎症性疾病。目前,心血管疾病导致的死亡人数约占全球总死亡人数的三分之一,而且由于肥胖症和糖尿病患病率的上升,预计这一比例在未来还会增加。目前针对动脉粥样硬化的治疗主要是调节脂质稳态,虽然在降低心血管疾病相关死亡风险方面取得了成功,但它们仍存在相当大的残余风险和各种副作用。因此,需要有旨在调节炎症以减少动脉粥样硬化形成的替代疗法。本综述将重点介绍细胞因子在疾病进展过程中所起的关键作用以及针对它们的潜在治疗策略。

相似文献

4
Nutraceuticals as therapeutic agents for atherosclerosis.营养保健品作为动脉粥样硬化的治疗药物。
Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1562-1572. doi: 10.1016/j.bbadis.2018.02.006. Epub 2018 Feb 14.
5
Functional diversity of macrophages in vascular biology and disease.巨噬细胞在血管生物学与疾病中的功能多样性
Vascul Pharmacol. 2017 Dec;99:13-22. doi: 10.1016/j.vph.2017.10.005. Epub 2017 Oct 24.
6
Immunotherapy for cardiovascular disease.免疫疗法治疗心血管疾病。
Eur Heart J. 2019 Dec 21;40(48):3937-3946. doi: 10.1093/eurheartj/ehz283.
9
n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms.n-3脂肪酸与心血管疾病:作用及分子机制
Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):319-26. doi: 10.1016/j.plefa.2007.10.014. Epub 2007 Dec 3.
10
Anti-inflammatory therapy in atherosclerosis.动脉粥样硬化的抗炎治疗。
Front Biosci (Landmark Ed). 2020 Jan 1;25(2):242-269. doi: 10.2741/4805.

引用本文的文献

本文引用的文献

1
Targeting and therapeutic peptides in nanomedicine for atherosclerosis.纳米医学中用于动脉粥样硬化的靶向和治疗性肽
Exp Biol Med (Maywood). 2016 May;241(9):891-8. doi: 10.1177/1535370216640940. Epub 2016 Mar 27.
10
Interferons as Essential Modulators of Atherosclerosis.干扰素作为动脉粥样硬化的基本调节物。
Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1579-88. doi: 10.1161/ATVBAHA.115.305464. Epub 2015 May 7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验